I have only taken a couple of casual looks at ACL over the years, but I would rather buy and hold the out-and-out market leader with the track record to match for long periods.
Unless ACL is at a can’t-refuse kind of valuation, or SHL is egregiously valued (which it is not - kind of middle-of-the-road), sticking with the industry top dog is the way to go generally.
Ann: Half Yearly Report and Accounts, page-25
-
- There are more pages in this discussion • 59 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SHL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$26.65 |
Change
0.400(1.52%) |
Mkt cap ! $12.80B | |||
| Open | High | Low | Value | Volume |
| $26.47 | $26.92 | $26.40 | $33.23M | 1.246M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 4137 | $26.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $26.68 | 6882 | 3 |
View Market Depth
| Last trade - 16.10pm 17/07/2024 (20 minute delay) ? |
| SHL (ASX) Chart |